(Total Views: 616)
Posted On: 03/16/2021 10:43:53 PM
Post# of 72447
It hasn’t been mentioned in recent PRs, but going back to Oct 2, the PR mentions the upcoming trial “with a planned interim analysis”
http://www.ipharminc.com/press-release/2020/1...f-covid-19
Anyone have any educated guesses as to what that means? I wouldn’t think they would provide interim analysis before the trial is fully recruited, so if we get a PR that states enrollment is full, maybe adding 29 days to that would give a rough estimate as to when we could get some news?
Also, does anyone with ipix, maybe cto or maybe even Leo, get unblinded data as it unfolds? I keep hearing people say that if brilacidin works really well they could stop the trial, as it would then be unethical to continue giving patients placebo. If that’s true, someone must have unblinded data.
Would appreciate someone’s take who has more trial knowledge/experience than me
I’m not expecting news on trial results until May/June, but wondering what others think
http://www.ipharminc.com/press-release/2020/1...f-covid-19
Anyone have any educated guesses as to what that means? I wouldn’t think they would provide interim analysis before the trial is fully recruited, so if we get a PR that states enrollment is full, maybe adding 29 days to that would give a rough estimate as to when we could get some news?
Also, does anyone with ipix, maybe cto or maybe even Leo, get unblinded data as it unfolds? I keep hearing people say that if brilacidin works really well they could stop the trial, as it would then be unethical to continue giving patients placebo. If that’s true, someone must have unblinded data.
Would appreciate someone’s take who has more trial knowledge/experience than me
I’m not expecting news on trial results until May/June, but wondering what others think
(0)
(0)
